0001437749-17-006118.txt : 20170405 0001437749-17-006118.hdr.sgml : 20170405 20170405130922 ACCESSION NUMBER: 0001437749-17-006118 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170403 FILED AS OF DATE: 20170405 DATE AS OF CHANGE: 20170405 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aviragen Therapeutics, Inc. CENTRAL INDEX KEY: 0000072444 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 591212264 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 2500 NORTHWINDS PARKWAY, SUITE 100 CITY: ALPHARETTA STATE: 2Q ZIP: 30009 BUSINESS PHONE: 301-770-3099 MAIL ADDRESS: STREET 1: 2500 NORTHWINDS PARKWAY, SUITE 100 CITY: ALPHARETTA STATE: 2Q ZIP: 30009 FORMER COMPANY: FORMER CONFORMED NAME: Biota Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20121113 FORMER COMPANY: FORMER CONFORMED NAME: NABI BIOPHARMACEUTICALS DATE OF NAME CHANGE: 20100719 FORMER COMPANY: FORMER CONFORMED NAME: NABI BIOPHARMACEUTICALS DATE OF NAME CHANGE: 20020304 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: COLONNESE MARK P CENTRAL INDEX KEY: 0001040766 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35285 FILM NUMBER: 17741851 MAIL ADDRESS: STREET 1: 8995 WESTSIDE PARKWAY CITY: ALPHARETTA STATE: GA ZIP: 30004 4 1 rdgdoc.xml FORM 4 X0306 4 2017-04-03 0000072444 Aviragen Therapeutics, Inc. AVIR 0001040766 COLONNESE MARK P 2500 NORTHWINDS PARKWAY STE 100 ALPHARETTA GA 30009 1 Chief Financial Officer Stock Option (Right to Buy) 0.656 2017-04-03 4 A 0 400000 0.656 A 2017-10-03 2027-04-03 Common Stock 400000 775000 D This stock option vests as follows: 33% of the total stock option vests six (6) months after the grant date, on October 3, 2017 and the remainder of the stock option vests in equal monthly installments beginning November 3, 2017 to April 3, 2018. /s/ Mark P Colonnese 2017-04-05